
I always felt like the ‘fat one' and cancelled nights out – I've lost 2st in 2 months on Mounjaro and got my fresh start
A MUM-of-two who used to cancel nights out because she felt like 'the fat one' has lost two stone in two months by using Mounjaro.
Sarah Hill, 32, from Glasgow, is among the estimated 1.5 million Brits that have used weight loss injections to get her dream body and a 'fresh start'.
7
7
She says: 'I tried everything – Cambridge, Slimming World, calorie counting – and at one point I lost five stone, but I couldn't keep it off."
But it was Mounjaro that finally helped her stick to healthy meals.
'Now I'm planning nights out again and actually showing up,' the assistant manager at a soft play centre said.
'I've got an outfit ready for this weekend and, for once, I'm excited.'
Sarah used to spend hours getting ready for nights out, only to cancel at the last minute because she felt as if she did not belong – and for years she hid in the shadows.
'I'd get my hair and makeup done to try and make my face look nice, but I couldn't bear the thought of my body in photos,' she recalls.
'I'd always be in black tights and floaty dresses, trying to cover up.'
Earlier this year, Sarah, who is 5ft 4in tall, reached her heaviest weight of 245lbs (17st and 7lbs), wearing a size 22.
Sarah said she has struggled with her weight 'since (she) was a teenager'.
'I was bullied in school and it just stuck with me,' she said.
'Even in PE, I'd hide in the toilets to get changed.'
Having her first child at 17, Sarah said her priorities shifted.
Sarah gave her all to all the most popular diet clubs but even if she lost weight, she said: 'I'd pile it back on and end up in an even worse place.
'I became obsessed with the scales. If I gained a pound, I'd feel like a failure.
'There were times I cried after weigh-ins.'
The breaking point came after her grandmother Sandra died at age 70 in July 2024.
'She had cancer, and I was one of her main carers at the end,' Sarah said.
'Losing her broke me. I was grieving, burned out, exhausted from work and barely moving.
'That's when I knew something had to change – not just for me, but for my kids.'
Sarah said she had seen people online talking about weight loss injections, but she did not believe it could work.
It was not until she saw friends and family members getting real results with the Slim Results programme, a weight management company, that she decided to give it a go.
Tirzepatide, the active ingredient in the jab Mounjaro, is injected weekly by the patient themselves.
It makes a person feel fuller for longer and, therefore, less hungry.
It is advised that anyone taking the injection should eat a balanced, reduced-calorie diet and exercise regularly.
'I was nervous at first – it's a medication, and there's still so much stigma, but I can honestly say it's the best decision I've ever made,' Sarah said.
Sarah experienced tiredness and constipation in the early weeks of jab, but she said the round-the-clock support from the Slim Results team made all the difference.
'They were brilliant,' she said. 'I thought I'd just be sent the jab and that's it, but they were there any time I needed advice – on nutrition, vitamins, everything.'
Her diet has also completely transformed.
She explained: 'I used to start the day with two sausage rolls and a large vanilla latte. Now it's overnight oats or fruit and an Americano with a splash of milk.
'Lunch is soup or salad, and dinner is usually a big plate of veg with some protein – I've always liked food, but now I enjoy meals that actually fuel me.'
Two months on, Sarah has dropped from 245lbs (17st and 7lbs) to 216lbs (15st and 6lbs).
One of the biggest differences, Sarah says, is her confidence. She is now wearing a size 14 to 16 and said a recent shopping trip felt like a milestone.
'I used to just avoid Primark like the plague because I felt like I couldn't wear anything,' she said. 'I came out with a massive bag yesterday.
7
7
'I was an XXL before, and I got larges and even some mediums. That was a big hit for me.
'I felt like I had to go to the plus-size ranges and online to find anything.
'Now I can walk in and pick something up. It feels amazing.'
She has also booked holidays she would have dreaded in the past.
'We're going to Disneyland with the kids in October and I'm not panicking about fitting on the rides or covering up in the heat,' she said.
'I just feel like a new person. I used to be the one behind the camera, never in them. Now I'm proud to be in the picture.'
Sarah said she still has a way to go, but for the first time, she believes she will get there.
As for Mounjaro, she says: 'People misunderstand weight loss injections.
'They think it's cheating or that you're lazy, but they've never lived in a body that feels like a burden.
'It's not just a jab. It's a fresh start.'
Everything you need to know about fat jabs
Weight loss jabs are all the rage as studies and patient stories reveal they help people shed flab at almost unbelievable rates, as well as appearing to reduce the risk of serious diseases.
Wegovy – a modified version of type 2 diabetes drug Ozempic – and Mounjaro are the leading weight loss injections used in the UK.
Wegovy, real name semaglutide, has been used on the NHS for years while Mounjaro (tirzepatide) is a newer and more powerful addition to the market.
Mounjaro accounts for most private prescriptions for weight loss and is set to join Wegovy as an NHS staple this year.
How do they work?
The jabs work by suppressing your appetite, making you eat less so your body burns fat for energy instead and you lose weight.
They do this my mimicking a hormone called GLP-1, which signals to the brain when the stomach is full, so the drugs are officially called GLP-1 receptor agonists.
They slow down digestion and increase insulin production, lowering blood sugar, which is why they were first developed to treat type 2 diabetes in which patients' sugar levels are too high.
Can I get them?
NHS prescriptions of weight loss drugs, mainly Wegovy and an older version called Saxenda (chemical name liraglutide), are controlled through specialist weight loss clinics.
Typically a patient will have to have a body mass index (BMI) of 30 or higher, classifying them as medically obese, and also have a weight-related health condition such as high blood pressure.
GPs generally do not prescribe the drugs for weight loss.
Private prescribers offer the jabs, most commonly Mounjaro, to anyone who is obese (BMI of 30+) or overweight (BMI 25-30) with a weight-related health risk.
Private pharmacies have been rapped for handing them out too easily and video calls or face-to-face appointments are now mandatory to check a patient is being truthful about their size and health.
Are there any risks?
Yes – side effects are common but most are relatively mild.
Around half of people taking the drug experience gut issues, including sickness, bloating, acid reflux, constipation and diarrhoea.
Dr Sarah Jarvis, GP and clinical consultant at patient.info, said: 'One of the more uncommon side effects is severe acute pancreatitis, which is extremely painful and happens to one in 500 people.'
Other uncommon side effects include altered taste, kidney problems, allergic reactions, gallbladder problems and hypoglycemia.
Evidence has so far been inconclusive about whether the injections are damaging to patients' mental health.
Figures obtained by The Sun show that, up to January 2025, 85 patient deaths in the UK were suspected to be linked to the medicines.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Telegraph
2 hours ago
- Telegraph
Trump to force NHS to pay for wonder drugs
NHS patients have been given new hope of accessing wonder drugs previously blocked in Britain as Donald Trump pressures the health service to spend more with US suppliers. Ministers are understood to be reviewing the value-for-money rules that govern which drugs the NHS can buy, amid demands from the Trump administration for the UK to be more welcoming to US pharmaceutical companies. Under the trade agreement signed between the two nations earlier this year, the Government agreed to 'endeavour to improve the overall environment for pharmaceutical companies operating in the UK'. Earlier this week, The Telegraph revealed that this could result in the NHS paying more for US drugs to see off criticism of the differences in medicine prices between the two nations. However, it is understood that discussions include not only paying more for treatments already supplied on the NHS but also making it easier for US drug giants to sell their most cutting-edge treatments to the health service. It follows a wave of high-profile rejections of so-called 'wonder' drugs in recent years. The National Institute of Health and Care Excellence (Nice), which approves new NHS drugs for purchase, has blocked treatments including one which stopped the progression of Alzheimer's disease and another that doubled the life expectancy for terminal breast cancer patients. Nice has rejected them based on assessments of how long they would extend a patient's lifespan and improve quality of life. To qualify under Nice rules a new treatment must deliver one extra year of perfect health, or longer for less perfect health, for no more than £30,000. This figure has not increased in line with inflation since 1999. If it had, it would be just over £53,000. Nice has maintained that, to get approval for use on the NHS, medicines 'must not only provide benefits to patients but also represent a good use of NHS resources and taxpayers' money'. However, critics say a failure to raise the threshold in-line with inflation meant life-changing drugs were being blocked. Richard Torbett, chief executive of the Association of the British Pharmaceutical Industry, said: 'There is growing evidence that it is becoming harder to bring new medicines to NHS patients. Increasingly, some new medicines may not be launched in the UK at all.' Companies including US giant Eli Lilly have said the regulator must rethink how 'value-for-money' is assessed. On Monday, a spokesman for the company said: 'The UK has historically focused on medicines as a cost to the NHS rather than evaluating their social and economic value.' Ministers are understood to be listening to demands from the industry for Nice to shake up its formula, with medicines such as AstraZeneca's breast cancer treatment Enhertu likely to be resubmitted for approval for NHS use if the formula is updated. Nice and AstraZeneca previously failed to reach an agreement over a price for the drug, which costs an estimated £118,000 per course of treatment. The NHS typically gets discounts, although the level is commercially sensitive. The Nice formula is being discussed after President Trump took a personal interest in the NHS issue. In trade documents between the US and UK, it said the NHS would review drug pricing to take into account the 'concerns of the president'. US officials are particularly concerned by an arrangement that sees companies pay revenue back to the NHS if costs rise faster than expected. Drug companies paid £3bn back to the NHS last year. In April, Wes Streeting, the Health Secretary, said he was proud that the UK had kept prices of medicines low. However, he admitted that the UK had become too focused on cost rather than the benefits in some cases. Mr Streeting said: 'We've moved from quite rightly trying to drive a good bargain on the price of drugs and treatment to a position where sometimes people view medicine spend as a dead weight cost'.


The Sun
2 hours ago
- The Sun
Millions of women live life by their menstrual cycle – including when they exercise & what they wear, study shows
A NEW tool tells women the best days of the month to exercise, go on a date, get dressed up for a party, and perform well at work. The calculator has been designed to determine when they will be at their best at different points in their monthly cycle. 1 The nifty asset allows women to input their usual length of cycle and date of last period, before plotting out exactly when they should do – or avoid – certain activities. It has been pulled together by natural period pain supplement monthlies, on the back of its research of 5,000 women in the UK. The findings show millions of women are governed by their menstrual cycle – and its pattern determines when they exercise, how they feel, and what they wear. It emerged 51 per cent feel controlled by their periods – to the extent 32 per cent say it dictates when they have sex, and 21 per cent what and when they eat. Socialising (23 per cent), sleep (20 per cent) and even when to commit to an important meeting (11 per cent) are among the things women plan around their time of the month. The study, by natural period pain supplement brand monthlies, found 54 per cent of those who experience period pain can pinpoint the exact days in the month it will occur. While 91 per cent experience ovulation pain mid-month – with discomfort when the ovaries release the egg felt around days 14 and 15 – with 63 per cent feeling this for more than two days. The average sufferer will also experience bloating for just over seven days of the month. And just seven per cent of lucky women claim to feel balanced and 'normal' for their entire monthly cycle. A spokeswoman for monthlies, which is designed to help with menstrual symptoms and cycle throughout the month, said: 'While this research gives us an 'average' picture of what the monthly cycle can look like, we know every single woman has their own unique set of experiences when it comes to having periods. Ex-Love Islander on what really happens when they get their period in tiny bikinis & the trick that DIDN'T work for her 'And while pain is more commonly felt the few days of bleeding, and at the mid-month point, this is not the case for everyone. 'Every woman needs to learn about their own period journey and work out what works best for them in terms of how to manage their period pain, as well as when to get the best out of themselves personally, professionally and socially.' Women generally do try to stay active for the majority of the month, including when they are on their period (44 per cent) and during ovulation (60 per cent). However, moods can fluctuate throughout the monthly cycle for two thirds of those polled, and six in 10 (59 per cent) often notice differences in their energy levels. Sleep, hunger, and productivity can also vary across the four week cycle. However, on the plus side, the research has highlighted that days 11 to 15 in the average woman's monthly cycle is when they feel the best, have the most energy and the most confidence. These days are also cited as those which are best to take a shopping trip, go out for the evening and feel nicest in clothing. With day 12 voted the best for having sex for the average person experiencing periods polled via OnePoll. The spokeswoman for added: 'Having a period isn't all bad, in fact at times it can be empowering, and depending on what our hormones are doing and when, we can often feel great. 'It's all about learning about your own body, what it responds to, how to look after it and realising that everyone is different.'


Times
3 hours ago
- Times
Natural birth v caesarean — what the latest statistics tell us
D octors in the UK are never short of reading material thanks to a continual stream of new guidance on various aspects of clinical practice, the latest of which is designed to improve the quality of care for anyone considering a caesarean birth. Colleagues working in specialities such as dermatology and orthopaedics can choose to ignore topics like this but we GPs are expected to know something about everything, so I read it over the weekend and want to share some of the highlights. Not least because they help to dispel a myth that regularly pops up on social media: namely that having a caesarean means you can avoid the continence problems that affect so many women after giving birth. First though, a caveat. While the National Institute for Health and Care Excellence (Nice) has gone to great lengths to assimilate the best evidence out there, it remains far from perfect. Indeed Nice starts the section comparing the risks and benefits of vaginal and caesarean deliveries — for mother and baby — with a warning that, despite compiling data from 30 years' worth of international research, they are not as reliable as it would like.